Title of Journal
Article: A Randomized Comparison of Sirolimus-Eluting
Stent With Balloon Angioplasty in Patients With In-Stent Restenosis
Title of Journal
Journal of the American College of Cardiology
Volume: 47, No. 11 Date:
6/6/2006 Page Number(s) 2153-2160
Elsevier Inc.
_____Poor ______Fair ______Good
_______Very Good __X__Excellent
This journal article deals with
drug eluting stents and their ability to slow patients in-stent restenosis.
Students: ____Poor ____Fair
_____Good __X__Very Good _____Excellent
Teachers: ____Poor ____Fair
_____Good _____Very Good __X__Excellent
Patients: ____Poor ____Fair
__X__Good _____Very Good _____Excellent
This article was
difficult to read at some points due to overwhelming medical terminology, but on careful review it was highly informative.
This journal article
uses quantitative research methods. It sets up experiments using the classic design for quantitative research.
Patients that had
previously been admitted to the hospital for balloon angioplasty were submitted to Sirolimus-Eluting Stents (SES) on any return
visit. The 150 patients were recorded and asked to return for a one-year clinical follow up. 76 patients received SES and
74 to balloon angioplasty. 88 percent of the SES group showed an improvement in their blood flow. Patients with in-stent restenois
that used SES showed greater long-term clinical health.
-
I learned that the drug in drug-eluting
stents is called Sirolimus and can be abbreviated as SES.
-
Balloon angioplasty (BA) is not as effective
as the placement of SES.
-
According to this article, SES are highly
recommended from a radiologic standpoint.
Once you gain an understanding
to the terms used, there are no real weaknesses to this article. The graphs and charts are easy to read, and it is highly
interesting.
This article will
help my studies by showing me how a good research project is desiged, and it will help my career if I am accepted into the
radiology program at ETSU.
Yes, it has 25 references
Your Name: Will
Hargis Date: 3/04/2009